Park S - Search Results

1

Clinical significance of soluble programmed cell death ligand-1 (sPD-L1) in hepatocellular carcinoma patients treated with radiotherapy.

Kim HJ, Park S, Kim KJ, Seong J. Kim HJ, et al. Among authors: park s. Radiother Oncol. 2018 Oct;129(1):130-135. doi: 10.1016/j.radonc.2017.11.027. Epub 2018 Jan 30. Radiother Oncol. 2018. PMID: 29366520

2

Plasma Cell-Free DNA as a Predictive Marker after Radiotherapy for Hepatocellular Carcinoma.

Park S, Lee EJ, Rim CH, Seong J. Park S, et al. Yonsei Med J. 2018 Jun;59(4):470-479. doi: 10.3349/ymj.2018.59.4.470. Yonsei Med J. 2018. PMID: 29749129 Free PMC article.

3

Compensatory hypertrophy of the liver after external beam radiotherapy for primary liver cancer.

Rim CH, Park S, Woo JY, Seong J. Rim CH, et al. Among authors: park s. Strahlenther Onkol. 2018 Nov;194(11):1017-1029. doi: 10.1007/s00066-018-1342-y. Epub 2018 Aug 13. Strahlenther Onkol. 2018. PMID: 30105451 English.

4

Acute severe lymphopenia by radiotherapy is associated with reduced overall survival in hepatocellular carcinoma.

Byun HK, Kim N, Park S, Seong J. Byun HK, et al. Among authors: park s. Strahlenther Onkol. 2019 Nov;195(11):1007-1017. doi: 10.1007/s00066-019-01462-5. Epub 2019 Apr 15. Strahlenther Onkol. 2019. PMID: 30989242 English.

5

Skeletal Muscle Depletion Predicts the Prognosis of Patients With Hepatocellular Carcinoma Treated With Radiotherapy.

Lee J, Cho Y, Park S, Kim JW, Lee IJ. Lee J, et al. Among authors: park s. Front Oncol. 2019 Oct 15;9:1075. doi: 10.3389/fonc.2019.01075. eCollection 2019. Front Oncol. 2019. PMID: 31681607 Free PMC article.

6

Irradiation-Related Lymphopenia for Bone Metastasis from Hepatocellular Carcinoma.

Park S, Byun HK, Seong J. Park S, et al. Liver Cancer. 2019 Nov;8(6):468-479. doi: 10.1159/000500461. Epub 2019 Jun 21. Liver Cancer. 2019. PMID: 31799204 Free PMC article.

7

Improved oncologic outcomes by ablative radiotherapy in patients with bone metastasis from hepatocellular carcinoma.

Kim TH, Park S, Rim CH, Choi C, Seong J. Kim TH, et al. Among authors: park s. J Cancer Res Clin Oncol. 2021 Sep;147(9):2693-2700. doi: 10.1007/s00432-021-03553-2. Epub 2021 Feb 13. J Cancer Res Clin Oncol. 2021. PMID: 33582874

8

Treatment outcome of radiation therapy and concurrent targeted molecular therapy in spinal metastasis from renal cell carcinoma.

Park S, Kim KH, Rhee WJ, Lee J, Cho Y, Koom WS. Park S, et al. Radiat Oncol J. 2016 Jun;34(2):128-34. doi: 10.3857/roj.2016.01718. Epub 2016 Jun 17. Radiat Oncol J. 2016. PMID: 27306772 Free PMC article.

9

Survival and Functional Outcome after Treatment for Primary Base of Tongue Cancer: A Comparison of Definitive Chemoradiotherapy versus Surgery Followed by Adjuvant Radiotherapy.

Park S, Cho Y, Lee J, Koh YW, Kim SH, Choi EC, Kim HR, Keum KC, Park KR, Lee CG. Park S, et al. Among authors: park kr. Cancer Res Treat. 2018 Oct;50(4):1214-1225. doi: 10.4143/crt.2017.498. Epub 2017 Dec 26. Cancer Res Treat. 2018. PMID: 29281874 Free PMC article.

10

Risk group-adapted adjuvant radiotherapy for WHO grade I and II skull base meningioma.

Park S, Cha YJ, Suh SH, Lee IJ, Lee KS, Hong CK, Kim JW. Park S, et al. J Cancer Res Clin Oncol. 2019 May;145(5):1351-1360. doi: 10.1007/s00432-019-02891-6. Epub 2019 Apr 5. J Cancer Res Clin Oncol. 2019. PMID: 30953136

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

66,064 results

Search Page

Filters